Treatment of orthostatic hypotension with dihydroergotamine.
作者信息
Jennings G, Esler M, Holmes R
出版信息
Br Med J. 1979 Aug 4;2(6185):307. doi: 10.1136/bmj.2.6185.307.
Abstract
摘要
相似文献
1
Treatment of orthostatic hypotension with dihydroergotamine.用双氢麦角胺治疗体位性低血压。
Br Med J. 1979 Aug 4;2(6185):307. doi: 10.1136/bmj.2.6185.307.
2
Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide.双氢麦角胺治疗灭鼠灵所致直立性低血压
Ann Intern Med. 1980 Mar;92(3):387-8. doi: 10.7326/0003-4819-92-3-387.
3
[A 64 year old female patient with orthostatic hypotension and syncopes].一名患有体位性低血压和晕厥的64岁女性患者。
Internist (Berl). 1980 Jan;21(1):50-3.
4
Postural hypotension--pathophysiology and management.体位性低血压——病理生理学与管理
Q J Med. 1986 Jul;60(231):643-57.
5
Postural hypotension and its management.
Practitioner. 1982 Mar;226(1365):420-2, 424, 426.
6
Treatment of orthostatic hypotension with dihydroergotamine and caffeine.用双氢麦角胺和咖啡因治疗直立性低血压。
Ann Intern Med. 1986 Aug;105(2):168-73. doi: 10.7326/0003-4819-105-2-168.
7
Treatment of orthostatic hypotension.
Clin Physiol. 1985;5 Suppl 5:94-6.
8
[Therapy of orthostatic hypotension].
Dtsch Med Wochenschr. 1999 Oct 15;124(41):1209-12. doi: 10.1055/s-2007-1024515.
9
[Action of dihydroergotamine in severe orthostatic hypotension. 16 cases].双氢麦角胺治疗严重直立性低血压的作用。16例报告
Presse Med. 1987 May 9;16(17):800-3.
10
Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs.二氢麦角胺治疗精神药物所致直立性低血压
Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):465-7.
引用本文的文献
1
Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure.麦角胺咖啡因联合治疗可改善自主神经衰竭患者坐位血压和晕厥前症状。
Front Physiol. 2014 Jul 24;5:270. doi: 10.3389/fphys.2014.00270. eCollection 2014.
2
An explanation of the unexpected efficacy of L-DOPS in pure autonomic failure.左旋多巴（L-DOPS）治疗纯自主神经功能衰竭意外疗效的解释。
Clin Auton Res. 2004 Dec;14(6):356-7. doi: 10.1007/s10286-004-0229-4.
3
Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.生物利用度低作为双氢麦角胺治疗直立性低血压明显无效的原因。
Br Med J. 1980 Jul 26;281(6235):275-6. doi: 10.1136/bmj.281.6235.275-a.
4
Bioavailability of dihydroergotamine in man.双氢麦角胺在人体中的生物利用度。
Br J Clin Pharmacol. 1982 Jun;13(6):785-90. doi: 10.1111/j.1365-2125.1982.tb01866.x.
5
Chronic hypotension.慢性低血压
J R Soc Med. 1982 Aug;75(8):577-80. doi: 10.1177/014107688207500801.
6
Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.双氢麦角胺的主要代谢产物8'-羟基双氢麦角胺对人体静脉收缩作用的研究。
Eur J Clin Pharmacol. 1984;26(2):239-42. doi: 10.1007/BF00630292.
7
Pharmacological actions of the main metabolites of dihydroergotamine.
Eur J Clin Pharmacol. 1984;26(6):699-705. doi: 10.1007/BF00541928.
8
Treatment of postural hypotension with aerosol ergotamine.用气雾剂麦角胺治疗体位性低血压。
CMAJ. 1988 Jul 1;139(1):51-2.
9
Treatment of postural hypotension. A review.
Drugs. 1990 Jan;39(1):74-85. doi: 10.2165/00003495-199039010-00007.
10
Pharmacokinetic investigation of oral and i.v. dihydroergotamine in healthy subjects.
Eur J Clin Pharmacol. 1991;41(6):597-602. doi: 10.1007/BF00314992.
本文引用的文献
1
Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation.
Clin Sci. 1970 Aug;39(2):183-201. doi: 10.1042/cs0390183.
2
Venoconstrictor effect of dihydroergotamine in superficial hand veins.双氢麦角胺对手背浅静脉的静脉收缩作用。
Eur J Clin Pharmacol. 1974;7(2):137-9. doi: 10.1007/BF00561328.
3
Central haemodynamic effects of dihydroergotamine in patients with orthostatic hypotension.双氢麦角胺对体位性低血压患者的中心血流动力学影响。
Acta Med Scand. 1972 Jan-Feb;191(1-2):115-20.
4
Haemodynamic effects of dihydroergotamine in patients with postural hypotension.双氢麦角胺对体位性低血压患者的血流动力学影响。
Acta Med Scand. 1974 Dec;196(6):473-7. doi: 10.1111/j.0954-6820.1974.tb01044.x.
5
Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.麦角生物碱治疗体位性障碍的药理学基础。
Cardiology. 1976;61 suppl 1:290-301. doi: 10.1159/000169822.
Zotero 插件